Publication | Closed Access

Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer

Metastatic Breast CancerBreast OncologyMedicinePharmacologyTrastuzumab TherapyBreast CancerPharmacotherapyClinical BenefitCancer TreatmentOncologyRadiation OncologyEndocrine-related Cancer